
Member of the European Parliament · Lithuania S&D
Vytenis Povilas Andriukaitis
MEP for Lithuania · Socialists & Democrats · Lietuvos socialdemokratų partija · official EP profile
As of 8 November 2026, Vytenis Povilas Andriukaitis (S&D, Lithuania) has declared 213 lobby meetings this term - rank 96 of 720 MEPs by declared meetings, a place shared with 2 other MEPs.
That is one of the fuller declaration sheets in the Parliament - 2.1× the average member, and it ranks 24 of 135 in the S&D group.
68% of this MEP's declared counterpart entries, including diplomatic and government entries, carry a declared EU Transparency Register link - above the like-for-like raw Parliament-wide share of 52%.
Compare with the rest: search and sort all 720 MEPs, or see every MEP from Lithuania.
Compared with the averages
Transparency this term
Monthly declared meetings (bars) and the share of all counterpart entries carrying a declared Register link, including diplomatic and government entries (line), July 2024 to November 2026. This is the same current-term window as the figures above, beginning 16 July 2024.
Current month, partial through 6 Nov 2026: 0 declared meetings in Nov 2026. Peak: 15 in Jan 2025.
Show the figures for each monthHide the monthly figures
| Month | Meetings | Linked |
|---|---|---|
| Jul 2024 | 9 | 40% |
| Aug 2024 | 1 | 100% |
| Sep 2024 | 12 | 50% |
| Oct 2024 | 12 | 77.8% |
| Nov 2024 | 10 | 90% |
| Dec 2024 | 11 | 91.7% |
| Jan 2025 | 15 | 82.4% |
| Feb 2025 | 12 | 84.6% |
| Mar 2025 | 14 | 71.4% |
| Apr 2025 | 8 | 62.5% |
| May 2025 | 7 | 87.5% |
| Jun 2025 | 7 | 85.7% |
| Jul 2025 | 8 | 50% |
| Aug 2025 | 0 | - |
| Sep 2025 | 8 | 50% |
| Oct 2025 | 4 | 50% |
| Nov 2025 | 8 | 50% |
| Dec 2025 | 4 | 0% |
| Jan 2026 | 4 | 75% |
| Feb 2026 | 5 | 40% |
| Mar 2026 | 14 | 66.7% |
| Apr 2026 | 12 | 78.9% |
| May 2026 | 10 | 46.2% |
| Jun 2026 | 7 | 57.1% |
| Jul 2026 | 3 | 66.7% |
| Aug 2026 | 0 | - |
| Sep 2026 | 4 | 50% |
| Oct 2026 | 4 | 80% |
| Nov 2026 | 0 | - |
Busiest month: 15 declared in January 2025. Months with no declared meetings have no Register-share value; a dashed stretch of the line joins the months either side.
Who Vytenis Povilas Andriukaitis meets most
Counterparts are merged by resolved Transparency Register identity where possible. An entry counts as register-linked above only when the MEP declaration itself carries a Register link.
Where the meetings cluster
Both lists count this term. Sector pages count the full 2016–2026 record, and committee pages show each member's current-term total across all subjects, so their figures for this member can be higher.
Most-met sectors this term
Health & pharma (117), Think tanks & research (20), Public affairs & consultancy (13)
Meetings by committee or delegation this term
Public Health (50), Environment, Climate and Food Safety (3), Delegation for relations with Central Asia (1), Delegation to the EU-Armenia, EU-Azerbaijan and EU-Georgia parliamentary committees (1)
Most recent declared meetings
| Date | Counterpart | Capacity | Subject |
|---|---|---|---|
| 15 Oct 2026 | Rud Pedersen Brussels↗; IQVIA Solutions B.V.↗ | Rapporteur | Biotech |
| 12 Oct 2026 | A. Menarini Industrie Farmaceutiche Riunite s.r.l.↗ | Rapporteur | Biotech Act |
| 7 Oct 2026 | Eastern and Central European and Central Asian Commission on Drug Policy↗ | Member | Drug Policy Reform |
| 6 Oct 2026 | Permanent Representation of the Czech Republic to the European Union Permanent Representation of the Slovak Republic to the European Union | Rapporteur | Biotech Act |
| 30 Sep 2026 | Health Policy Watch | Member | Exchange of views |
| 15 Sep 2026 | Mission of the United Kingdom to the EU | Rapporteur | Biotech Act |
| 8 Sep 2026 | Friends of Europe↗ | Member | European Biotechnology sector |
| 1 Sep 2026 | European Society of Anaesthesiology and Intensive Care↗ | Member | Exchange of views |
| 14 Jul 2026 | EURORDIS | Member | Rare Diseases |
| 8 Jul 2026 | Kangaroo Group↗ | Member | Health as geopolitical asset |
Show 20 more meetingsShow fewer meetings
| Date | Counterpart | Capacity | Subject |
|---|---|---|---|
| 6 Jul 2026 | EuropaBio↗ | Member | European Biotech Sector |
| 30 Jun 2026 | Mission of Republic Moldova to the EU | Member | Enlargement |
| 24 Jun 2026 | BEAM Alliance↗ | Member | Exchange of Views |
| 23 Jun 2026 | Genmab A/S↗ | Rapporteur | Biotech Act |
| 22 Jun 2026 | European Landowners’ Organization | Member | Future of Ukraine's agricultural acession |
| 17 Jun 2026 | Permanent Representation of the Kingdom of the Netherlands to the European Union | Rapporteur | Biotech Act |
| 17 Jun 2026 | CropLife Europe↗ | Rapporteur | Biotech Act and Food and Feed Omnibus |
| 2 Jun 2026 | Merck↗ | Rapporteur | Biotech Act |
| 21 May 2026 | A. Menarini Industrie Farmaceutiche Riunite s.r.l. | Rapporteur | Biotech Act |
| 21 May 2026 | Copa-Cogeca | Member | NGT |
| 20 May 2026 | Kangaroo Group↗ | Member | EU Own Resources discussion |
| 18 May 2026 | EUROPEAN ORGANISATION FOR RARE DISEASES↗ | Rapporteur | Biotech Act |
| 13 May 2026 | BIOTON S.A.; Bayer AG↗; Deutsche Sozialversicherung Europavertretung European Federation of Pharmaceutical Industries and Associations IQVIA Solutions B.V. MEDICINES FOR EUROPE Rijksinstituut voor ziekte- en invaliditeitsverzekering | Rapporteur | Biotech Act |
| 12 May 2026 | European Centre for Disease Prevention and Control (ECDC); IQVIA Solutions B.V.↗ | Rapporteur | Biotech Act |
| 8 May 2026 | The Brewers of Europe↗ | Member | Food labeling |
| 7 May 2026 | European CRO Federation European Federation of Pharmaceutical Industries and Associations IQVIA Solutions B.V. | Rapporteur | Biotech Act |
| 4 May 2026 | EFPIA | Rapporteur | Biotech act |
| 4 May 2026 | GSK↗ | Rapporteur | Biotech Act |
| 28 Apr 2026 | American Chamber of Commerce to the European Union↗; Brunswick Group Limited srl↗; EUCOPE | Rapporteur | Biotech Act |
| 22 Apr 2026 | Kaneka Belgium N.V.↗; Food Supplements Europe↗; Bristol-Myers Squibb Company↗ | Rapporteur | Biotech act |
The full record is in the official EP declarations.
Roll-call voting record
Recorded votes only. Parliament held 6,412 roll-call votes while Vytenis Povilas Andriukaitis held the seat, 606 of them the final vote on a text. A member with no vote recorded may have been on parliamentary business, ill, on leave, or present without voting - the published record does not distinguish these and gives no reason. Votes taken by show of hands or by secret ballot are not recorded by name and are absent here.
How they voted on final texts
Share of the 606 final votes held while seated.
With and against the group
On the 589 final texts where more than half of S&D members casting a vote went one way, and Vytenis Povilas Andriukaitis also voted. Groups are not bound to vote together: a Member's mandate is personal and exercised freely, so neither figure is a measure of performance.
Final texts where Vytenis Povilas Andriukaitis differed from the S&D majority
| Date | Text | Their vote | S&D majority |
|---|---|---|---|
| 21 October 2026 | Motion for a resolution on the draft Commission implementing decision renewing the authorisation for placing on the market of products containing, consisting of or produced from genetically modified soybean MON 87769 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council B10-0469/2026 · Motion for a resolution (as a whole) | Abstained | For |
| 16 September 2026 | Motion for a resolution on the draft Commission implementing decision authorising the placing on the market of products containing, consisting of or produced from genetically modified soybean MON 94313 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council B10-0379/2026 · Motion for a resolution | Abstained | For |
| 16 September 2026 | Motion for a resolution on the draft Commission implementing decision authorising the placing on the market of products containing, consisting of or produced from genetically modified soybean GMB151 x DAS-44406-6 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council B10-0380/2026 · Motion for a resolution | Abstained | For |
| 16 September 2026 | Motion for a resolution on the draft Commission implementing decision renewing the authorisation for the placing on the market of products containing, consisting of or produced from genetically modified maize MON 87460 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council B10-0381/2026 · Motion for a resolution | Abstained | For |
| 15 September 2026 | Amending Decision (EU) 2015/1814 as regards ceasing the invalidation of allowances in the market stability reserve A10-0230/2026 · Pierfrancesco Maran · Commission proposal | Against | For |
| 8 July 2026 | Motion for a resolution on the Commission Implementing Decision renewing the authorisation for the placing on the market of products containing, consisting of or produced from genetically modified maize NK603 × T25 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council B10-0335/2026 · Motion for a resolution (as a whole) | Abstained | For |
| 8 July 2026 | Motion for a resolution on the draft Commission Implementing decision authorising the placing on the market of products containing, consisting of or produced from genetically modified maize DP202216 x NK603 x DAS-40278-9 and its sub-combinations DP202216 x NK603, DP202216 x DAS-40278-9, pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council B10-0336/2026 · Motion for a resolution (as a whole) | Abstained | For |
| 8 July 2026 | Motion for a resolution on the draft Commission implementing decision renewing the authorisation for the placing on the market of products containing, consisting of or produced from genetically modified soybean MON 87705 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council B10-0334/2026 · Motion for a resolution (as a whole) | Abstained | For |
| 21 May 2026 | Advancing towards a care society: addressing the gender care gap A10-0083/2026 · Eleonora Meleti and Rosa Estaràs Ferragut · Motion for a resolution (as a whole) | Against | Abstained |
| 30 April 2026 | RC-B10-0217/2026 - Joint motion for a resolution (subject not given in the vote record) RC-B10-0217/2026 · Motion for a resolution (as a whole) | Abstained | For |
31 further instances are not listed. All roll-call votes.
Unlinked but matchable
42 counterpart entries in Vytenis Povilas Andriukaitis's declarations appear to match an EU Transparency Register entry without being linked in the declaration:
- “BRAINS FOR BRAIN FOUNDATION” - likely BRAINS FOR BRAIN FOUNDATION (6 counterpart entries)
- “EFPIA” - likely European Federation of Pharmaceutical Industries and Associations (3 counterpart entries)
- “EURORDIS” - likely EUROPEAN ORGANISATION FOR RARE DISEASES (2 counterpart entries)
These are the 3 most frequent matches, covering 11 of the 42 entries; the other 31 are not listed.
Matching is automated and can be wrong - see how matching works. Linking the register entry is the fix, and it is the MEP office's to make.